Published in Drug Week, August 17th, 2001
Trelstar LA is a controlled-release formulation of triptorelin which delivers triptorelin continuously over a period of three months after intramuscular injection. Extensive clinical studies comparing the effectiveness of the already approved one-month controlled-release formulation of triptorelin (Trelstar Depot 3.75 mg) and the new...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.